Anna Durbin, MD
Professor, International Health and Medicine, expertise in the vaccine sciences, HIV clinician. As faculty at the Center for Immunization Research, she has acted as the Principal Investigator for more than 35 vaccine clinical trials. Her laboratory is responsible for performing the immunogenicity assays for these vaccines, including neutralizing antibody assays, ELISAs, and flow cytometry. Dr. Durbin has developed controlled human infection models for dengue and Zika and utilized these models to better understand the immunopathology of these viruses and also to evaluate the efficacy of candidate vaccines.
William Moss, MD, MPH
Professor, Epidemiology, International Health and Molecular Microbiology and Immunology. He is a pediatrician with subspecialty training in infectious diseases who has conducted studies of infectious diseases in children for 30 years in Ethiopia, Kenya, South Africa, Zambia, Zimbabwe and India among other countries. He is Executive Director of the International Vaccine Access Center, a Deputy Director of the Johns Hopkins Malaria Research Institute, and Project Director of the Southern and Central Africa International Centers of Excellence for Malaria Research.
Andrea Cox, MD, PhD
Professor, Medicine and Oncology, expert in innate immune sensing and T cell immunology, HIV clinician. She was the principal investigator on the first prophylactic HCV vaccine trial ever implemented in an at-risk population and her laboratory performed the immunogenicity assays for the trial, including antibody and ELISpot assays and flow cytometry. She is the lead immunologist on ACTG 5379, a trial of hepatitis B virus vaccines in HIV infected patients. She is also the co-director of the Johns Hopkins SARS-CoV-2 Pathogenesis and Immunity Center.
